Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neximmune Inc (NEXI)

Neximmune Inc (NEXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neximmune Inc 9119 GAITHER ROAD GAITHERSBURG MD 20877 USA

www.neximmune.com P: 301-825-9810

Description:

NexImmune Inc. is a clinical-stage biotechnology company. It engages in developing a novel approach to immunotherapy designed to employ the body's own T cells to generate a specific, potent and durable immune response that mimics natural biology. NexImmune Inc. is based in GAITHERSBURG, Md.

Key Statistics

Overview:

Market Capitalization, $K 4,525
Enterprise Value, $K -30,175
Shares Outstanding, K 1,371
Annual Sales, $ 0 K
Annual Net Income, $ -62,510 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,850 K
EBIT, $ -44,860 K
EBITDA, $ -43,870 K
60-Month Beta 1.84
% of Insider Shareholders 19.40%
% of Institutional Shareholders 9.85%
Float, K 1,105
% Float 80.60%
Short Volume Ratio 0.57

Growth:

1-Year Return -65.93%
3-Year Return -99.32%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.99 on 04/16/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -42.15
EPS Growth vs. Prev Qtr 46.91%
EPS Growth vs. Prev Year 69.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/19/23

NEXI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -247.17%
Return-on-Assets % -167.39%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.44
Book Value/Share 7.78
Interest Coverage -2.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar